Meda AB (publ) AGM bulletin

At the annual general meeting (AGM) on May 6, 2015, of Meda AB (publ), corporate ID 556427-2812, Box 906, SE-170 09 Solna, Sweden, declared an unchanged dividend of 2,50 SEK per share.

The AGM adopted balance sheets and income statements and discharged the members of the board and the CEO from liability.

The board was elected according to the nomination committee´s revised proposal. The nomination committee’s proposal for remuneration to the board and the auditors was adopted.

The AGM authorized the board to make decisions on the issue of shares, and on buying and selling Meda shares.

The AGM resolved on the implementation of a long-term performance-based incentive program.

Details of the AGM resolutions are available at Meda’s head office at pipers väg 2A, Solna Sweden, or by calling +46 8 630 1900. They will be sent on request free of charge to shareholders who provide an address.

The board

For further inquiries, please contact:

Paula Treutiger, VP Corporate Communications & Sustainability                                     ph: +46 733-666 599                                                                                                                                                                                                        

MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.


Documents & Links